The current status of perioperative chemotherapy for invasive bladder cancer: A multiinstitutional retrospective study in Japan

International Journal of Clinical Oncology

Volumn 10, Issue 2, 2005, Pages 133-138

  Matsui, Yoshiyuki ^a   Nishiyama, Hiroyuki ^a   Watanabe, Jun ^a   Teramukai, Satoshi ^b   Ono, Yoshinari ^c   Ohshima, Shinichi ^c   Fujimoto, Kiyohide ^d   Hirao, Yoshihiko ^d   Fukushima, Masanori ^b   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adjuvant chemotherapy; Bladder cancer; Neoadjuvant chemotherapy; Overall survival; Radical cystectomy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; INVASIVE CARCINOMA; JAPAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZATION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STRATIFICATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; CYSTECTOMY; DOXORUBICIN; EPIRUBICIN; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 20844463055     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0474-5     Document Type: Article

References (25)

1. Raghavan D, Shipley WU, Garnick MB, et al. (1990) Biology and management of bladder cancer. N Engl J Med 322:1129-1138
2. Giuliani L, Giberti C, Martorana G, et al. (1985) Results of radical cystectomy for primary bladder cancer. Retrospective study of more than 200 cases. Urology 26:243-248
3. Pagano F, Bassi P, Galetti TP, et al. (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145:45-50
4. Advanced Bladder Cancer Meta-analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361:1927-1934
5. Hussain SA, James ND (2003) The systemic treatment of advanced and metastatic bladder cancer. Lancet Oncol 4:489-497
6. Sternberg CN, Yagoda A, Scher HI, et al. (1985) Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133:403-407
7. Studer UE, Bacchi M, Biedermann C, et al. (1994) Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol 152:81-84
8. Freiha F, Reese J, Torti FM (1996) A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155:495-499
9. Martinez-Pineiro JA, Gonzalez Martin M, Arocena F, et al. (1995) Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study. J Urol 153:964-973
10. Malmstrom PU, Rintala E, Hellsten S (2001) The Nordic experience of cooperative urinary bladder cancer trials. Semin Urol Oncol 19:69-70
11. International Collaboration of Trialists (1999) Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscleinvasive bladder cancer: a randomised controlled trial. Lancet 354:533-540
12. Nishiyama H, Habuchi T, Watanabe J, et al. (2004) Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. Eur Urol 45:176-181
13. Fleming ID, Cooper JS, Henson DE, et al. (eds) (1997) AJCC cancer staging manual. 5th edn. Lippincott-Raven, Philadelphia, pp 241-243
14. Kuroda M, Kotake T, Akaza H, et al. (1998) Efficacy of dose-intensified MEC (methotrexate, epirubicin and cisplatin) chemotherapy for advanced urothelial carcinoma: a prospective randomized trial comparing MEC and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). Japanese Urothelial Cancer Research Group. Jpn J Clin Oncol 28:497-501
15. Sternberg JJ, Bracken RB, Handel PB, et al. (1977) Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report. JAMA 238:2282-2287
16. Oshima S, Ono Y, Fujita T, et al. (1987) Three-drug combination chemotherapy for advanced urothelial tract carcinoma. Cancer Chemother Pharmacol 20 Suppl:S20-S23
17. Chau I, Cunningham D. (2002) Adjuvant therapy in colon cancer: current status and future directions.Cancer Treat Rev 28:223-236
18. Maehara Y, Baba H, Sugimachi K. (2001) Adjuvant chemotherapy for gastric cancer: a comprehensive review. Gastric Cancer 4:175-184
19. Skinner DG, Daniels JR, Russell CA, et al. (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145:459-464
20. Stockle M, Meyenburg W, Wellek S, et al. (1992) Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and three adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 148:302-306
21. Wallace DM, Raghavan D, Kelly KA, et al. (1991) Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol 67:608-615
22. Bassi P, Pappagallo GL, Sperandio P, et al. (1999) Neoadjuvant MVAC chemotherapy of invasive bladder cancer: results of a multicenter phase III trial (abstract). J Urol 161:264a
23. Grossman HB, Natale RB, Tangen CM, et al. (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859-866
24. von der Maase H, Hansen SW, Roberts JT, et al. (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18:3068-3077
25. Roth BJ, Dreicer R, Einhorn LH, et al. (1994) Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. J Clin Oncol 12:2264-2270